These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18783074)

  • 61. Genetic screening and diagnosis.
    Lau TK; Leung TN
    Curr Opin Obstet Gynecol; 2005 Apr; 17(2):163-9. PubMed ID: 15758610
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Huntington disease-unaffected fetus diagnosed from maternal plasma using QF-PCR.
    González-González MC; Trujillo MJ; Rodríguez de Alba M; García-Hoyos M; Lorda-Sánchez I; Díaz-Recasens J; Ayuso C; Ramos C
    Prenat Diagn; 2003 Mar; 23(3):232-4. PubMed ID: 12627425
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An endocrine model for the diagnosis of intrauterine growth retardation as demonstrated by the determination of total estrogen and pregnandiol 24-hour urinary excretion in 222 at risk pregnancies.
    Wolfrum R; Bordasch C; Holweg J
    J Perinat Med; 1975; 3(4):248-59. PubMed ID: 1225959
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Maldi-tof mass spectrometry compared with real-time PCR for detection of fetal cell-free DNA in maternal plasma.
    Li Y; Holzgreve W; Kiefer V; Hahn S
    Clin Chem; 2006 Dec; 52(12):2311-2. PubMed ID: 17138855
    [No Abstract]   [Full Text] [Related]  

  • 65. Noninvasive Prenatal Diagnosis of Single-Gene Disorders by Use of Droplet Digital PCR.
    Camunas-Soler J; Lee H; Hudgins L; Hintz SR; Blumenfeld YJ; El-Sayed YY; Quake SR
    Clin Chem; 2018 Feb; 64(2):336-345. PubMed ID: 29097507
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Progress of research on biochemistry characteristics of cell-free fetal DNA in maternal plasma and its application].
    Deng ZH; Li DC
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Jun; 24(3):314-8. PubMed ID: 17557245
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review.
    Bakry R; Rainer M; Huck CW; Bonn GK
    Anal Chim Acta; 2011 Mar; 690(1):26-34. PubMed ID: 21414433
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Detection of single-copy fetal DNA sequence from maternal blood.
    Lo YM; Patel P; Sampietro M; Gillmer MD; Fleming KA; Wainscoat JS
    Lancet; 1990 Jun; 335(8703):1463-4. PubMed ID: 1972235
    [No Abstract]   [Full Text] [Related]  

  • 69. Free circulating nucleic acids in plasma and serum (CNAPS) -- Useful for the detection of lung cancer patients?
    Fleischhacker M; Schmidt B
    Cancer Biomark; 2010; 6(3-4):211-9. PubMed ID: 20660966
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Meeting report - First international symposium on circulating nucleic acids in plasma/serum - Implications in cancer diagnostics, prognosis or follow up and in prenatal diagnosis - Menthon France, August 18-20, 1999.
    Fleischhacker M
    Eur J Med Res; 1999 Nov; 4(11):488-90. PubMed ID: 10585305
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cell-free fetal DNA in the maternal serum and plasma: current and evolving applications.
    Avent ND; Madgett TE; Maddocks DG; Soothill PW
    Curr Opin Obstet Gynecol; 2009 Apr; 21(2):175-9. PubMed ID: 19262379
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Non-invasive prenatal diagnosis from the perspective of a low-resource country.
    Ventura W; Nazario-Redondo C; Sekizawa A
    Int J Gynaecol Obstet; 2013 Sep; 122(3):270-3. PubMed ID: 23790745
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Invasive procedures for prenatal diagnosis: any future left?
    Simpson JL
    Best Pract Res Clin Obstet Gynaecol; 2012 Oct; 26(5):625-38. PubMed ID: 22749621
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Discovery and identification of sequence polymorphisms and mutations with MALDI-TOF MS.
    van den Boom D; Ehrich M
    Methods Mol Biol; 2007; 366():287-306. PubMed ID: 17568131
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Amplification methods in the molecular diagnosis of genetic diseases.
    Ben-Ezra JM
    Clin Lab Med; 1995 Dec; 15(4):795-815. PubMed ID: 8838224
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Detection of fetal mutations causing hemoglobinopathies by non-invasive prenatal diagnosis from maternal plasma.
    D'Souza E; Sawant PM; Nadkarni AH; Gorakshakar A; Ghosh K; Colah RB
    J Postgrad Med; 2013; 59(1):15-20. PubMed ID: 23525053
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Early and midtrimester genetic amniocenteses. Safety and outcomes.
    Reece EA
    Obstet Gynecol Clin North Am; 1997 Mar; 24(1):71-81. PubMed ID: 9086519
    [TBL] [Abstract][Full Text] [Related]  

  • 78. MALDI mass spectrometry for nucleic acid analysis.
    Gao X; Tan BH; Sugrue RJ; Tang K
    Top Curr Chem; 2013; 331():55-77. PubMed ID: 23019094
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Fluorescent PCR: a new technique for PGD of sex and single-gene defects.
    Findlay I; Quirke P; Hall J; Rutherford A
    J Assist Reprod Genet; 1996 Feb; 13(2):96-103. PubMed ID: 8688597
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Applications of MALDI-TOF mass spectrometry in clinical proteomics.
    Greco V; Piras C; Pieroni L; Ronci M; Putignani L; Roncada P; Urbani A
    Expert Rev Proteomics; 2018 Aug; 15(8):683-696. PubMed ID: 30058389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.